berberine and palmatine were identified. The modes of action of these compounds were investigated by determining their effects on enzymes with important roles in membrane and cell wall biosynthesis of C. albicans.
Introduction
There is a need for novel antifungal drugs, as some of the currently available antimycotics are frequently toxic at therapeutic dosage, and there have been several reports of the isolation of strains of important fungal pathogens which are resistant to antifungals. [1] [2] [3] [4] [5] Chinese and Korean medicinal plant extracts have been used to treat a wide range of diseases for many hundreds of years. 6 There have been very few reports of the use of these plant extracts to treat human mycoses. Medicinal herbs may represent a valuable, untapped source of novel antifungal drugs; the widespread use of extracts (e.g. berberine and palmatine, Figure 1 ) from these herbs to treat non-fungal systemic disease [7] [8] [9] [10] [11] [12] [13] suggests that antifungals isolated from these plants should lack host toxicity. Protoberberines ( Figure 1 ) are alkaloids that may be extracted readily from Chinese and Korean medicinal plants. Extracts containing both berberine and palmatine, and pure berberine formulations, have been administered orally or injected intramuscularly to treat conditions ranging from bacterial disease to hypertension. [6] [7] [8] [9] [10] [11] [12] [13] Comparatively little is known of the potential of protoberberines as antifungal agents. Berberine has been shown to inhibit the growth of Candida albicans, Candida glabrata and Candida tropicalis, but mechanisms of antifungal action have not been described. 14 In the course of screening for novel antifungal agents from Korean medicinal plants, several extracts were identified, which caused significant inhibition of growth of a range of Candida spp. The active agents were purified from Coptis rhizoma and Phellodendron amurense and both 
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Materials and methods
Organism and culture condition
The fungal isolates used were C. albicans (ATCC10231, -11651, -28838), and clinical isolates of Candida krusei, Candida parapsilosis, C. glabrata and Candida guilliermondii (the culture collection of the Department of Microbiology, University of Leeds, UK). Cells were maintained on slopes of Sabouraud's dextrose agar (Difco, Detroit, MI, USA) at 4ЊC. To obtain yeast growth forms, cells were inoculated into Sabouraud's dextrose broth, pH 5.6, and incubated for 18 h at 30ЊC, as a shake culture as described. 15 Late exponential phase cells (18 h) were harvested and washed by centrifugation, and used for the preparation of microsomes. Mycelial forms of C. albicans were prepared by incubating cells in Sabouraud's dextrose broth containing 20% (v/v) newborn bovine serum at 37ЊC for 24 h. 16 
Preparation of microsomes of C. albicans
The preparation of microsomes of C. albicans was based on the method of Ator et al. 17 Harvested cells (mycelial growth form: 65-70% of total cells were hyphae) were suspended in 2.5 vol. of 0.1 M potassium phosphate (pH 7.4, 1 mM ethylenediamine tetra-acetic acid (EDTA)), and centrifuged at 5000g for 5 min. 
Extraction and purification of medicinal herbs using organic solvents
The plants were purchased from the Korean medicinal herb dispensary (Hanyakyutong Co.) in Seoul and subjected to methanolic extraction as described. 19 Briefly, about 200 g of powders of dried medicinal plants that include Ligustrum lucidum, Anemarrhena asphodeloides, Phellodendron amurense, Coptis rhizoma and Corydalis yanhusuo were extracted with 3 vol. of 80% methanol by refluxing for 3 h. The extracts were filtered, and the fil t r a t e s c o n c e n trated by evaporation in vacuo to dryness. Total methanolic extracts were subjected to a bioactivity-guided fractionation procedure. Dried filtrates were extracted with 2 vol. of dichloromethane. The dichloromethanesoluble fractions were dried with magnesium sulphate and lyophilized. These organic fractions were further purified by thin layer chromatography (TLC) using n-hexane as solvent. The bands with antifungal activity were extracted with n-hexane and purified with high-performance liquid chromatography (HPLC) employing C-18 octyl column using dichloromethane-ethanol (95:5) and a UV detector. 19 Collected active antifungal fractions were crystallized (e.g. approximately 120 mg of palmatine) from methanol. The purified compounds were identified as berberine and palmatine when they were subjected to mass spectrometry (MS), nuclear magnetic resonance spectrometry (NMR) and infrared (IR) spectral analyses. There was good agreement between the isolated protoberberines and authentic commercial sources (Sigma, St Louis, MO, USA) with respect to MS, IR, and NMR (data not shown).
Agar diffusion susceptibility test
Molten medium (yeast nitrogen base with 1% glucose; YNBG) was allowed to cool to 50ЊC and 20 mL aliquots were poured into 100 ϫ 15 mm round Petri dishes as described. 20 After the agar had solidified at room temperature, any excess surface moisture or droplets on the agar surface were eliminated by incubating the plates at 35ЊC for no longer than 30 min. Seven Candida spp. including C. albicans (ATCC10231), C. albicans (ATCC28838), C. albicans (ATCC11651), C. parapsilosis, C. glabrata, C. guilliermondii and C. krusei were used in this study. Inocula of these test Candida spp. were standardized by making water suspensions from the 24 h cultures and adjusting them to match the turbidity of a 10 4 cells/mL standard. Sterile, nontoxic swabs were dipped into the adjusted suspensions and the YNBG agar plates inoculated. The entire dried surface of the agar was streaked three times by rotating the plates 60Њ each time. Miconazole and dried methanolic extracts of medicinal herbs were dissolved in dimethylsulphoxide (DMSO, final concentration not exceeding 0.3% w/v). Discs (8 mm) (Whatman, Kent, UK) were soaked in these solutions to give final contents of 200 g of miconazole and 4000 g of medicinal herbs. The prepared discs, plus blank controls, were applied to the plates, which were placed in an incubator within 15 min, and incubated at 35ЊC for 48 h. Following incubation, zones of inhibition were measured with a ruler.
Broth microdilution susceptibility test
Test compounds dissolved in the stock solution (0.3%, w/v, DMSO), were diluted in Rosewell Park Memorial Institute (RPMI) 1640 medium (pH 7.0) and 100 L of each agent was applied to 96-well plates. The MIC values of the various agents, including miconazole and amphotericin B, were determined by a broth dilution method using microdilution in 96-well microtitre trays. 21 Each of seven Candida spp. cells was inoculated to approximately 2 ϫ 10 4 cells/mL in 100 L medium, containing doubling dilutions of the agents. The addition of cell suspension to each well created a final range of antifungal agent concentrations from 100 to 0.05 mg/L. The trays were covered with loosefitting lids and incubated for 72 h at 35ЊC. MIC values were determined three times, and only representative data are shown here.
Sterol biosynthesis assay
Washed cells of C. albicans (ATCC10231) were incubated with radiolabelled substrates as described elsewhere. 22, 23 Briefly, washed cells were incubated in medium A (yeast nitrogen base (YNB) without amino acid and 1% (w/v) glucose, pH 6.5) for 18 h at 30ЊC, then the cells were harvested and washed. Washed cells were resuspended in medium B (0.1 mM potassium phosphate buffer and 1% (w/v) glucose). An aliquot consisted of a 980 L cell suspension (2 ϫ 10 9 cells/mL) in a 15 mL capped tube at 30ЊC. Protoberberines or miconazole were dissolved in DMSO (to give a final concentration of 0.12 M) and cells were preincubated with drug for 10 min. The reaction was initiated by addition of 10 L of [
14 C]acetate (1 microcurie (Ci), specific activity 56 mCi/mmol) or L-[methyl-
14 C]methionine (1 Ci, specific activity 1 mCi/mmol) and the cells were incubated for 3 h. The reaction was stopped by addition of 1 mL 15% (w/v) KOH, 90% ethanol and the samples were saponifie d at 80ЊC for 1 h. The non-saponifia b l e lipids were then extracted with petroleum ether and the samples evaporated to dryness. Extracts were dissolved in 60 L chloroform and loaded on to TLC plates. The plates were eluted with toluene-diethyl ether (9:1). Bands were visualized under UV light, identified using standards and cut out, and the radioactivity was determined by liquid scintillation counting (Beckman 6500; Beckman, Palo Alto, CA, USA).
Assay of sterol ∆
-methyl transferase (24-SMT)
Enzyme assays were conducted by a slight modification of the method of Ator et al. 17 The assay mixture contained 0.1 M Tris-HCl (pH 7.5), 0.4 mg microsomal protein, 30 mM KHCO 3 , 5 mM MgCl 2 , 200 M desmosterol, and 50 M [methyl- 14 C]S-adenosylmethionine (SAM) (0.25 Ci) in a volume of 500 L, in an assay vial. Aqueous desmosterol solutions were prepared as suspensions with nonionic detergent Triton WR-1339 (tyloxapol; Sigma, St Louis, MO, USA) as described. 24 Assays were incubated at 30ЊC in a shaking water bath for 25 min to determine the initial velocity of the reaction. The reactions were terminated by addition of 500
Ci, specific activity 46 Ci/mmol). Extraction of products was carried out as for sterol biosynthesis above. The amount of radioactivity present was determined by double-label scintillation counting.
Assay of chitin synthase
The chitin synthase (CS) assays were carried out by the method of Causier et al. 25 The reaction mixture (50 L) contained 50 g microsomes that had been preincubated with trypsin and 40 mM Tris-HCl (pH 7.5), 6 mM MnCl 2 , 32 mM GlcNAc and 1 mM UDP-N-acetyl-D-glucosamine (GlcNAc) containing 9 nCi UDP-[U-
14 C]GlcNAc (271 mCi/mmol). Incubation was carried out at 25ЊC for 60 min. The reaction was stopped by heating the samples at 100ЊC for 2 min. The reaction mixture was filtered through glassfibre filter paper (Whatman GF/F glass microfibre filters (Whatman); 2.5 cm diameter, 0.7 m pore size) that had been soaked in distilled water for 60 min. The reaction tube was washed twice with 50 L aqueous Triton X-100 (1%, v/v), and the filters were washed with 10 mL distilled water. Radioactivity of the filters was determined by liquid scintillation counting. Nikkomycin Z was used as a positive control for CS inhibition. 26 
Chemicals and reagents
Results
Effect of the selected medicinal herbs on Candida spp.
It has been previously reported that the total MeOH extracts of a dozen medicinal herbs exhibit anti-Candida activity. 27 This study was designed to examine their relative anti-Candida activities, the nature of the inhibitory component of the bioactive extracts and the mode of action of these compounds. Of the 12 MeOH extracts examined, only five showed Ͼ30% growth inhibition of C. albicans at 10 mg/assay and were therefore considered active (data not shown). To explore further the anti-Candida potential of the five selected herbal extracts, their inhibitory activity at lower doses (i.e. 4000 g/assay) was examined using an agar diffusion assay. As summarized in Table I , of the five different extracts, only C. rhizoma and P. amurense were found to exhibit significant anti-Candida activity against most of the Candida spp. tested. Following extensive purification of these MeOH extracts, 19 the major active components of two herbal extracts (C. rhizoma and P. amurense) were determined to be berberine and palmatine (Figure 1 ). Further biochemical investigation of the anti-Candida activity has focused on these protoberberines with respect to target site, and mechanism of action and relative potency as anti-Candida agents.
In-vitro anti-Candida activity of the protoberberines
To examine whether the protoberberines (berberine and palmatine) inhibit the growth of Candida spp.and to determine their relative anti-Candida activity, cells were grown in the presence of each compound and MIC values measured. As summarized in Table II , for C. albicans, berberine gave MIC values in vitro ranging from 125 to 250 mg/L, depending on the isolate tested. MIC values for the other species of Candida were from 4 mg/L (C. krusei) to Ͼ500 mg/L (C. parapsilosis). Palmatine was not effective against most Candida species examined, at a dose of Ͼ500 mg/L, but caused significant inhibition of C. parapsilosis growth (MIC
mg/L). Further investigations concentrated on C. albicans (ATCC10231).
Effect of protoberberines on sterol ∆
-methyl transferase (24-SMT) activity in vivo and in vitro
To determine the target site for the inhibitory activity of the protoberberines, ergosterol biosynthesis was measured in the presence and absence of these compounds. Total cellular sterols in C. albicans were synthesized in the presence of either [ 1 4 C]acetate or [ 1 4 C]mevalonate and berberine. In the first experiment, using [ 1 4 C]mevalonate or [ 1 4 C ] a c e t a t e as an ergosterol precursor, there was no difference in C]acetate or mevalonate exclusively into the ergosterol fraction (results not shown). This indicates that the target may not be an enzyme involved in the biosynthesis of the carbon skeleton of ergosterol, from either acetate or mevalonate. In the second experiment, L-[ m e t h y l- 1 4 C]methionine was added to C. albicans, which had been cultured previously in a medium devoid of amino acids, in phosphate buffer containing glucose (1%, w/v). Ergosterol biosynthesis was measured by incorporation of L-[ m e t h y l - 1 4 C]methionine, and the effects of protoberberines were examined. As shown in Figure 2a , incorporation of L-[ m e t h y l- 1 4 C]methionine into the C-24 of ergosterol was strongly inhibited by the presence of berberine or palmatine in a dose-dependent manner; the former compound was the more potent inhibitor. The decrease in the incorporation of L-[ m e t h y l- 1 4 C]methionine into ergosterol appears to be a consequence of the inhibition of sterol 24-methyl transferase (24-SMT), which is the only enzyme that catalyses transmethylation from S-adenosylmethionine. The results shown in Figure 2b indicate a dose-dependent inhibition of the rate of L-[ m e t h y l- 1 4 C]methionine incorporation into ergosterol by protoberberines. The IC 5 0 values of the protoberberines in inhibition of ergosterol synthesis from L-[ m e t h y l- 1 4 C]methionine were approximately 25 M (berberine) and 300 M (palmatine) (Figure 2b) .
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To determine whether the protoberberines specifically inhibit 24-SMT activity, an enzyme assay was carried out in the presence of the protoberberines. As shown in Figure  3a , both berberine and palmatine inhibited equally yeast microsomal 24-SMT in a similar dose-dependent manner. It is known that there are major differences in the composition of phospholipids and free fatty acids of lipids in the membranes of yeast and mycelial growth forms of C. albicans. 28 To determine whether this difference between the two forms has any impact on the anti-Candida activity of the protoberberines, 16 enzyme assays were carried out using 24-SMT preparations isolated from the yeast and mycelial growth forms of C. albicans. As shown in Figure   671 3b and 3c, inhibition of 24-SMT from the mycelial form was more marked than the inhibition of 24-SMT from the yeast form. For example, at a dose of 50 M berberine, mycelial 24-SMT activity was about 66% of the control and yeast 24-SMT activity was approximately 90% of the control. This trend appeared to be maintained at higher doses. The mode of inhibition of yeast 24-SMT by berberine and palmatine was noncompetitive with K i of 232 M (berberine) and 257 M (palmatine) (Figure 4a and b) . Taken together, these results suggest that the anti-Candida activity of the protoberberines is attributable, at least in part, to inhibition of 24-SMT activity.
Inhibition of chitin synthase activity by palmatine
In an attempt to identify other target sites for protoberberines in C. albicans, the effect of these compounds on CS activity in vitro was determined. Palmatine caused a moderate dose-dependent inhibition of CS isolated from yeast or mycelial growth forms (data not shown). The mode of inhibition by palmatine was noncompetitive with a K i of 780 M. However, berberine had little effect on CS activity (data not shown).
Discussion
Min et al. 2 7 demonstrated that methanol extracts of medicinal herbs inhibit growth of C. albicans. This study shows that similar extracts from Korean medicinal plants have promising antifungal activity against a range of Candida spp., which are becoming increasingly important as opportunistic fungal pathogens. 29 The protoberberines berberine and palmatine, isolated from one of these plants, exhibited marked antifungal activity. Berberine was a potent inhibitor of C. krusei and C. guilliermondii, whereas palmatine was highly toxic for C. parapsilosis. Nakamoto et al.
14 reported higher MIC values of berberine for C. albicans. This anomaly may be due to differences between the growth inhibition tests used during these studies. In this study a microdilution assay was used, whereas Nakamoto et al. 14 employed agar diffusion. Relatively high concentrations of protoberberines were required to inhibit sterol and chitin biosynthesis in vitro. The more marked effects of these compounds on growth of pathogenic fungi may be explained by postulating a combined effect of protoberberines on two biosynthetic pathways in these organisms, leading to significant antifungal activity in vivo.
The pathways of sterol biosynthesis in fungi are targeted by important antifungal drugs, and many of the enzymes that contribute to fungal cell wall biosynthesis are considered potential targets for novel antimycotics. 30, 31 The results of the present study are of considerable significance, as it was demonstrated that a novel class of antifungals, the protoberberines, inhibit key enzymes in the pathways of both ergosterol and chitin biosynthesis. Both palmatine and berberine inhibited microsomal CS from the yeast and mycelial growth forms of C. albicans, although the degree of enzyme inhibition was much less than noted for nikkomycin Z. 32 Palmatine was a non-competitive inhibitor of yeast CS with K i 780 M (data not shown). These observations indicate that the protoberberines used during the present study are not potent inhibitors of C. albicans chitin synthase. It remains to be seen whether synthetic or semisynthetic derivatives of these compounds may prove to be more powerful inhibitors of enzyme activity. It will be of interest to establish whether all of the isoforms of CS in C. albicans 33, 34 are inhibited by protoberberine antifungals. When C. albicans yeast cells were incubated in the presence of berberine or palmatine, the protoberberines caused a dose-dependent inhibition of incorporation of radioactivity from L-[methyl-
14 C]methionine into ergosterol (Figure 2 ). This effect appeared to be a consequence of the inhibition of 24-SMT, the only enzyme that catalyses transmethylation from S-adenosylmethionine. Both berberine and palmatine inhibited 24-SMT activity in microsomes, isolated from the yeast or mycelial growth forms of C. albicans (Figure 3) . Inhibition of 24-SMT activity in vivo will result in the accumulation of ergosta-8,24-dien-3 -ol and depletion of ergosterol. Both of these effects are likely to contribute to the antifungal properties of the protoberberines. 24-SMT from the mycelial growth form was more susceptible than the yeast enzyme to berberine and palmatine. This may be an important consideration if protoberberines are to be used to treat candidoses in the clinic, as the mycelial form of C. albicans is thought to have an important role during the pathogenesis of infection. 3 5 The effects o f protoberberines on ergosterol biosynthesis in C. albicans appear to involve a specific inhibition of 24-SMT activity, because neither berberine nor palmatine at 1 mM had any effect on other steps of sterol synthesis, when [ 14 C]mevalonate or [ 14 C]acetate was used in vivo as substrate (data not shown). In a recent study, inhibition of 24-SMT activity was shown to block sterol biosynthesis and cell proliferation in Pneumocystis carinii. 36, 37 These results, coupled with the findings of the present study, suggest that 24-SMT may present an important target for antifungals.
In conclusion, the demonstration that antifungal protoberberines inhibit both 24-SMT and chitin synthase in C. albicans provides a basis for the design of novel antimycotics based on the protoberberine nucleus. These results, and the long history of the successful use of berberine and plant extracts containing this, and related compounds, in Chinese and Korean medicine, provide a basis for the further investigation and development of protoberberines, with potent antifungal activity and low host toxicity.
